Dr Arvind Gupta reviews the latest research on the ocular effects of GLP-1 receptor agonists
With over 300 genes now associated with IRDs, genetic diagnosis is possible in up to 80% of patients
Te Whatu Ora has released a new National Diabetes Roadmap
Come on tour of the Corneal Lens Corporation’s (CLC) laboratory in Christchurch